 |
Edotreotide |
|---|---|
| Trade Name | Onalta(Tm) |
| Orphan Indication | Somatostatin receptor-positive neuroendocrine gastroenteropancreatic tumors |
| USA Market Approval | USA |
| USA Designation Date | 2005-07-28 00:00:00 |
| Sponsor | Molecular Insight Pharmaceuticals, Inc. (Progenics Subsidiary);777 Old Saw Mill River Road;Tarrytown, New York, 10591 |
